Exelixis director Lance Willsey resigns; Board adds Farallon nominee, ends proxy fight

EXELIXIS, INC.

Lance Willsey, M.D. resigned from Exelixis board effective May 7, 2023; resignation relates to personal matter from over a decade ago.
Board will not contest Farallon's additional nominee David Johnson at May 31, 2023 Annual Meeting; recommends voting for its 10 remaining nominees.
Board previously nominated two Farallon candidates (Tomas Heyman, Robert Oliver) to replace two existing directors.
Board commits to replacing two additional directors over next two years (one per year) with new independent directors.
Over three years, five directors will have transitioned off, four new independent directors elected, including all Farallon nominees.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Lance Willsey

Director

EXEL · EXELIXIS, INC.

Effective: 2023-05-07
Filed: May 8, 2023, 7:59 PM ET

On May 7, 2023, the Board of Directors (the “Board”) of Exelixis, Inc. (the “Company”) announced that Dr. Lance Willsey was resigning from the Board effective immediately

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Lance Willsey resigned as Director at EXELIXIS, INC..

Action: resigned
Role: Director

Exact text from the filing

On May 7, 2023, the Board of Directors (the “Board”) of Exelixis, Inc. (the “Company”) announced that Dr. Lance Willsey was resigning from the Board effective immediately

View on SEC.gov

EXELIXIS, INC. filing history →

Source: SEC EDGAR

accession 0000950142-23-001374

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.